Purpose. Group B Streptococcus (GBS) is one of the major pathogens in severe materno-neonatal infections. We aimed to describe the clinical and molecular characteristics of GBS isolates causing infections in 45 maternal and 50 neonatal subjects, collected from eight healthcare centres in mainland China over the period 2010-2017.
INTRODUCTION
Group B Streptococcus (GBS), a common commensal colonizer of the gastrointestinal and urogenital tracts found in 10-30 % of pregnant women, is a leading life-threatening agent of neonatal pneumonia, septicaemia and meningitis [1] [2] [3] [4] [5] . The lung is the main portal of microorganism entry. Particularly noteworthy, it can also pose a threat to mothers during pregnancy and delivery [6] . Since 1996, intra-partum antimicrobial prophylaxis (IAP) in GBS carriers has been recommended to reduce materno-fetal transmission during delivery to prevent perinatal diseases, by the Centers for Disease Control and Prevention in the USA. The guidelines were updated and republished in 2002 and 2010, respectively. The implementation of the guidelines resulted in a dramatic decline in early-onset disease (EOD). However, the incidence of late-onset disease (LOD) has remained virtually unchanged [1] . The pathway and timescale of GBS transmission in LOD remain unclear and controversial. GBS isolates in LOD may have resulted from either mother-child transmission or environmental sources [7, 8] . Development of a vaccine is the most promising method for the prevention of the two types of GBS infections [9, 10] .
GBS is divided into 10 serotypes (Ia, Ib, II-IX) based on capsular polysaccharide (cps) [11, 12] . As a crucial virulence factor, cps is capable of stimulating antibody-based immunity. The cps-based vaccine covers the majority of GBS strains [2, 10, 13] . Moreover, GBS pili harbour three subunits -a backbone pilin protein and two ancillary proteinsencoded by two loci in different regions of the genome, and designated pilus islands (PI) 1 and 2 [10, 14] . The ubiquitous presence of pilus islands in GBS isolates render these structures promising vaccine candidates against neonatal infections [9, 14] . Multilocus sequence typing (MLST) based on seven housekeeping genes allows for the classification of most human carriage and clinical GBS isolates into six major clonal complexes (CCs), namely CC1, CC10, CC17, CC19, CC23 and CC26, among which CC26 is mainly reported from African countries [15, 16] .
Resistance to erythromycin and clindamycin, used in penicillin-hypersensitive patients, has been reported worldwide [17] [18] [19] . Phenotypic erythromycin-resistant GBS isolates were classified based on resistance mechanisms. Briefly, erythromycin resistance methylase (encoded by erm) modifies 23S rRNA, leading to co-resistance toward lincosamide and streptogramin B, defined as the macrolide-lincosamide-streptogramin B (MLSB) resistance phenotype. MLSB resistance includes both inducible and constitutive MLSB (iMLSB and cMLSB, respectively). Isolates with the cMLSB phenotype constitutively express rRNA methylase, whereas those with the iMLSB phenotype produce methylase only in the presence of an inducing agent and display erythromycin resistance and clindamycin susceptibility. This can readily be identified by the double-disc synergy test (D test) [20] . The second mechanism, represented by the M type, involves an efflux pump (encoded by mef) and shows no cross-resistance to lincosamide and streptogramin B. When the D test is negative, those isolates with erythromycin resistance and clindamycin susceptibility are defined as phenotype M, while those GBS isolates resistant to clindamycin but susceptible to erythromycin are defined as phenotype L.
We previously reported the epidemiological characteristics of GBS colonized from pregnant Chinese women [12, 21] . However, the features of GBS in materno-neonatal infections have rarely been documented. Therefore, to demonstrate the phenotypic and genotypic characteristics of infective GBS isolated from Chinese mothers and infants, we initiated an epidemical investigation on those GBS isolates causing materno-neonatal infections. Our results are also compared to globally reported data.
METHODS
Case definition EOD is defined as infections in newborns within the first week of life (0-6 days) due to vertical transmission from a colonized mother just before or during delivery. LOD is defined as infections in infants after the first week of life (7-89 days) [1, 5] . Maternal infection is defined as infections confirmed by the laboratory, such as culture-confirmed bacteraemia, amnionitis, chorioamnionitis or meningitis [22] . Invasive infection refers to laboratory isolation of GBS from a normally sterile site with any signs of clinical disease (e.g. sepsis or meningitis) [2] .
Bacterial isolates
Between 2010 to 2017, the GBS isolates in this study were recovered from infected neonates and mothers who visited the following medical institutes, with timeframe indicated in parentheses: Civil Aviation General Hospital (CAGH, C with 5 % CO 2 for 18-24 h. The isolates were further identified on the basis of colony morphology, CAMP (Christie-Atkins-MunchPetersen) test, Lancefield grouping by latex agglutination test (streptococcal grouping kit, Oxoid), and 16S rRNA sequencing if necessary. GBS strains isolated from both mother and infant concurrently were excluded. Furthermore, when GBS strains from different resources (cerebrospinal fluid (CSF), blood, etc.) had identical morphological characteristics, identification results and antibiotic susceptibility profiles, only one isolate was chosen for further study.
Therefore, a total of 95 non-redundant GBS isolates responsible for materno-neonatal infections were collected from patients aged 2 h~6 days with EOD (28 cases), 7~71 days with LOD (22) and 24~41 years with maternal infections (45). The demographic characteristics of the patients and detailed information on these strains are shown in Table 1 and Fig. 1 .
Determination of cps serotyping and pilus island gene profile Molecular capsule typing was performed by amplifying cps type-specific regions of Ia, Ib and II-IX, and those isolates that failed to be typed were assigned to non-typeable (NT) [11] . PCR assays were also used to identify the pilus islands using primers as described [21, 23] .
MLST, phylogenetic and epidemiological analyses MLST was performed by amplifying and sequencing the internal fragments within seven housekeeping genes as described previously [24] . The sequence types (STs) and allelic numbers were subsequently further identified by querying the MLST database (http://pubmlst.org/sagalactiae). GBS isolates were assigned to one CC if they shared five or more alleles with the predominant ST. BioNumrics software version 5.1 (Applied Maths, Belgium) was used to create Antibiotic susceptibility testing and macrolide and tetracycline resistance genotyping The broth microdilution method was used to determine the susceptibility of all isolates to penicillin G, ampicillin, ceftriaxone, erythromycin, clindamycin, levofloxacin, tetracycline and vancomycin. Cation-adjusted Mueller-Hinton broth, supplemented with lysed horse blood (2.5-5 % v/v) was provided by the Tianjing Jinzhang Science and Technology Development, China. Antibiotic susceptibility testing was performed in accordance with the breakpoints set for Streptococcus spp. b-haemolytic group by the Clinical and Laboratory Standards Institute [20] . All antibiotic susceptibility data were analysed using WHONET 5.6 software, as recommended by the World Health Organization.
Genetyping of erm(A) [subclass erm(TR)], erm(B) and mef (A/E) was performed by PCR in all GBS isolates, regardless of their antibiotic susceptibilities to erythromycin, according to our previous study [25] . Moreover, tetracycline-resistant genes, including tet(M), tet(K), tet(L) and tet(O), were also detected using PCR [25] .
RESULTS

Infection sources and cps distribution
In this study, a total of 95 GBS isolates from materno-neonatal infections were collected from eight tertiary hospitals in China, as shown in Fig. 1 . More than half of the isolates (50, 52.6 %) were recovered from newborns, and 57.9 % (55 isolates) from patients with bacteraemia and/or meningitis ( (Fig. 3) ; the most prevalent complex was CC10 (28, 29.5 %), followed by CC17 (26, 27.4 %) and CC19 (20, 21.1 %). All hypervirulent CC17 harboured serotype III, accounting for 51.0 % (26/51) of serotype III isolates.
Pilus islands
As shown in Figs 2 
Antibiotic susceptibility testing and resistance phenotypes and genotypes
The antimicrobial susceptibility and MIC results for eight antimicrobial agents tested against all 95 GBS isolates are presented in Table 2 . Our results demonstrate that all GBS strains were uniformly susceptible to penicillin, ampicillin, ceftriaxone and vancomycin. In contrast, 78.9 % (75 isolates), 76.8 % (73) and 81.1 % (77) of GBS isolates were resistant to erythromycin, clindamycin and tetracycline, respectively.
The erythromycin-resistant GBS isolates were distributed in all serotypes and CCs. Furthermore, cMLSB accounted for 71.6 % (68 isolates) of resistant isolates. The majority of cMLSB isolates carried erm(B) or both mef(A/E) and erm(B). Four M phenotype isolates were associated with the presence of an efflux encoded by the genetic determinant mef(A/E), whereas the iMLSB resistance phenotype was found in two isolates containing the genes erm(B) and mef(A/E) and in one with only the mef(A/E) gene. No significant correlation was detected among macrolide resistance phenotypes, serotypes and CCs. The pattern of tetracycline resistance was extensively disseminated, with 65 of 77 (84.4 %) tetracycline-resistant isolates harbouring the tet(M) gene, singly or in combination. All resistant isolates contained at least one of the known resistance genes. 
DISCUSSION
Increasing evidence shows that GBS strains, if colonized as a commensal in the genitourinary tract of pregnant women, play an important role in severe materno-neonatal infections [3, [26] [27] [28] . For newborns, GBS infection rate is highest during birth and up to 3 months of age, but declines dramatically thereafter. Case fatality from both EOD and LOD is high, even with timely and suitable antibiotic therapy [6] . For mothers, GBS is also an important factor in intrauterine infection and puerperal sepsis [6] . Understanding the epidemiological characteristics of GBS is essential to the development of effective prevention and treatment.
In the current study, the onset of 89.3 % EOD (25/28) was seen during the first day after birth. Similarly, in France, 90 % of 174 EOD cases occurred during the first 48 h of life (median age: 1 day, range: 0-6 days) [4] . Taking these results together, the occurrence time of EOD was not evenly distributed, and newborns (the first 24 h) with risk factors should be under strict surveillance. Furthermore, during our study period, EOD and LOD accounted for 56.0 and 44.0 % of neonatal diseases, respectively. In contrast, LOD represented approximately 60 % of neonatal GBS diseases in France where intravenous IAP is routinely implemented [4] . In developed countries, prevention of EOD through the use of IAP during labour has been adopted for pregnant women with risk factors or identified as carrying GBS by screening [1, 5, 27] , and this resulted in a dramatic decline in EOD [1, 28] . However, to date, no national IAP has been performed in mainland China.
Serotype is the most important epidemiological marker of GBS infections, since this may differ both geographically and temporally. In this study, the predominant serotype observed was III (53.7 %), followed by V (13.7 %), Ib (13.7 %) and Ia (6.3 %). Furthermore, 12/22 (54.5 %) GBS isolates causing LOD carried serotype III. In our previous study on GBS isolates colonizing in Chinese pregnant women, serotype distribution was as follows: III (45.0 %), Ia (20.6 %), Ib (11.3 %) and V (14.4 %) [21] . One previous study suggested that serotype V strains might result in a higher percentage of invasive disease in non-pregnant adults compared with neonates [29] . This was not demonstrated in our study, which could be explained by geographical differences [30] . In comparison, in France, serotype III was linked to 57 % EOD and 80 % LOD, respectively [4] . Furthermore, serotype III represented 75 % of GBS isolates responsible for neonatal meningitis, comparable to the 70 % previously documented in Canada [29] . Globally, a recent meta-analysis showed that the distribution of serotypes in neonatal infections was III (49 %), Ia (23 %), V (9 %), Ib (7 %), II (6 %) and NT (3 %) [5] . Several cps-based GBS vaccines are at various stages of testing and may allow prevention of both EOD and LOD [3, 9, 31] . In line with our work, current trialled pentavalent (Ia, Ib, II, III and V) and trivalent (Ia, Ib and III) conjugate vaccines would provide reasonably good population coverage [92.6 % (88/95) and 73.7 % (70/ 95), respectively] if implemented in mainland China.
Besides capsular typing, MLST is often applied in the evaluation of the clonal relationship among GBS isolates. Differences in CCs distribution have previously been noted across varied populations [4, 29, 30 ]. In the current study, GBS strains showed a high degree of genetic diversity: 95 isolates belonged to 17 STs and were clustered into the six main CCs, and most of these have been detected worldwide [4, 32, 33] except for the minor complex CC862. The data derived from the present study, together with prior results, have demonstrated that certain GBS strains are associated with neonatal diseases [9, 34] . Specifically, GBS strains representing hypervirulent CC17 with enhanced invasiveness were shown to disproportionately affect neonates and cause severe invasive disease, e.g. meningitis, more frequently than other strains of CCs [23, 29, 35] . In this study, CC17 sublinage was detected more in both LOD (9/22, 40.9 %) and EOD (10/28, 35.7 %) than in maternal infection (7/45, 15.6 %) and in colonized isolates (8.8 %) [21] . It is noteworthy that CC862 (containing ST862 and ST651) is a specific clone mainly distributed in China, 30 % (3/10) of which was identified in neonatal infections, and was assigned as CC485 according to a previous study by Li et al. [34] . The data from our study represented the diversity of the entire collection and included many isolates recovered from multiple sources. The GBS isolates from our enrolled subjects showed geographical distribution variance: 90 % (9/10) of CC862 originated from a hospital in Xiamen City and only one isolate from the blood of a mother in Nannning City, showing the emergence of a newly selected CC and a regional feature. [9] . In the current study, at least one PI was present in all isolates, consistent with a report by Martins et al. [36] . Therefore, a pilus-based vaccine would cover both colonizing and infective GBS isolates across different populations in China [21] . Previous studies have suggested there was a strong association between pilus islands and serotype distribution [9, 21, 34, 37] . For example, in the current study, all serotype Ib isolates carried PI-2a. The concomitant presence of PI-1 and PI-2a was the most frequent combination, and almost ubiquitous in CC19 and CC10, similar to findings from a previous study [9] . This relationship can be explained by the genetic link between GBS serotypes and pilus islands. The combination of PI-1 and PI-2b was rarely identified in colonized isolates [21] ; however, the carriage of PI-2b, singly or in combination, was closely associated with neonatal infection [7, 9, 36] .
It is noteworthy that the high susceptibility to penicillin, ampicillin and ceftriaxone in all isolates suggests the practice of using these antibiotics as the first-line agent for both treatment and prophylaxis. GBS resistance rates to erythromycin in this study are alarmingly higher than those found in both Brazil (4.1 %) [18] and Italy (12.0 %) [19] . Herein, among macrolide-resistant strains the erm(B) genotype was prevalent, mainly associated with the cMLSB resistance phenotype. The high rate of tetracycline resistance observed is consistent with results obtained from our previous studies in China [30] . In regard to tetracycline resistance genes, tet (M) and tet(O) were detected in 84.4 % (65/77) and 72.7 % (56/77) of tetracycline-resistant isolates in the present study, in contrast to a study from Brazil in which 99.3 and 1.8 % of isolates carried tet(M) or tet(O), respectively, and five harboured both genes [18] . [4, 7, 36] . Finally, the distribution of PI genes was different: PI-2b, singly or in combination, was identified less frequently in maternal infections than in neonatal infections [38.2 % (21/55) vs 22.2 % (10/45)], respectively. In our study, only three GBS strains harboured PI-2b alone, two strains in the highly pathogenic CC17 lineage and one in CC862. Our observations have reinforced the fact that more attention should be paid to the hypervirulent CC-17-and PI-2b-(singly or in combination) containing GBS isolates that were largely predominant in neonatal infections, compared to the case numbers in maternal infections.
Conclusion
In summary, our study has comprehensively investigated the clinical and molecular characteristics of GBS causing materno-neonatal infections in mainland China. The data demonstrated that genetically distinct lineages were detected in GBS isolates. A relatively high frequency of the sublineages CC17/PI-1 and PI-2b in neonatal infections, high resistance rates to erythromycin and clindamycin, as well as a high prevalence of serotype III were notable features of neonatal GBS strains in China. The study has provided useful evidence for the implementation of effective national IAP or vaccine-based prevention strategies.
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